{
  "pmid": "41471111",
  "title": "Oral Treatment of Obesity by GLP-1 and Its Analogs.",
  "abstract": "Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics for treatment of type 2 diabetes mellitus and have since become an established drug class for improving glycemic control. The interest in GLP-1 for obesity treatment has surged in 2015 after the approval of Saxenda",
  "disease": "diabetes mellitus"
}